AngioDynamics, Inc.
ANGO
$9.22
$0.111.21%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.93% | -4.23% | -7.88% | -14.22% | -22.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.93% | -4.23% | -7.88% | -14.22% | -22.06% |
| Cost of Revenue | 16.86% | -15.70% | -15.13% | -20.33% | -27.40% |
| Gross Profit | 9.61% | 8.35% | -0.88% | -8.33% | -16.92% |
| SG&A Expenses | 4.83% | 0.12% | 3.67% | -4.16% | -4.08% |
| Depreciation & Amortization | 0.54% | -20.96% | -28.07% | -29.10% | -41.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12% | -9.37% | -9.17% | -13.81% | -17.88% |
| Operating Income | 37.42% | 42.68% | 24.45% | 10.47% | -139.09% |
| Income Before Tax | 56.79% | 97.79% | 14.03% | -136.33% | 35.33% |
| Income Tax Expenses | 91.33% | 99.98% | -100.67% | 101.21% | -73.87% |
| Earnings from Continuing Operations | 55.02% | 97.65% | 63.03% | -127.89% | 37.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.02% | 97.65% | 63.03% | -127.89% | 37.35% |
| EBIT | 37.42% | 42.68% | 24.45% | 10.47% | -139.09% |
| EBITDA | 13.54% | 91.93% | 6,996.15% | 36.69% | -127.06% |
| EPS Basic | 55.64% | 97.69% | 63.67% | -127.34% | 38.62% |
| Normalized Basic EPS | 29.06% | 90.66% | 23.63% | 18.03% | -55.96% |
| EPS Diluted | 55.36% | 97.64% | 63.67% | -127.37% | 37.88% |
| Normalized Diluted EPS | 29.06% | 90.66% | 23.63% | 17.76% | -55.96% |
| Average Basic Shares Outstanding | 1.38% | 1.54% | 1.75% | 2.04% | 2.07% |
| Average Diluted Shares Outstanding | 1.38% | 1.54% | 1.75% | 1.71% | 2.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |